alternaria allergen
Allergenexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT01134757)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetImmunity, desensitized
Immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS52B29REC7H ↗
Also known as
- alternaria allergen
- alternaria alternata allergen extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01984528 | Phase 2 | Feb 1, 2014 | Leti Pharma GmbH, Universidad Autonoma de Madrid |
| NCT01134757 | N/A | Jan 1, 2011 | J. W. Goethe University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| J. W. Goethe University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Leti Pharma GmbH | For profit | 1 | 1 | 1 | 2014 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1